<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0026-1742</journal-id>
<journal-title><![CDATA[Revista de la Facultad de Medicina (México)]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Fac. Med. (Méx.)]]></abbrev-journal-title>
<issn>0026-1742</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional Autónoma de México, Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0026-17422014000600011</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Situación del brote de Ébola en África Occidental en el año 2014]]></article-title>
<article-title xml:lang="en"><![CDATA[Status Ebola outbreak in West Africa in 2014]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Anaya Velarde]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Durán Arenas]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,UNAM Facultad de Medicina Departamento de Salud Pública]]></institution>
<addr-line><![CDATA[ DF]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2014</year>
</pub-date>
<volume>57</volume>
<numero>6</numero>
<fpage>11</fpage>
<lpage>16</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0026-17422014000600011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0026-17422014000600011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0026-17422014000600011&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Desde el comienzo del brote en diciembre del 2013, y hasta el corte del 20 de septiembre de 2014, de un total de 6,185 casos probables de Ébola, se han registrado un total de 2,909 defunciones. Con una letalidad inferior al 50%, considerablemente menor a la reportada en brotes previos de la enfermedad, se cree que dichas estimaciones están sesgadas debido a la dificultad en la recolección y análisis de la información. El 23 de septiembre, la OMS presentó una revisión a dichas estimaciones, señalando una letalidad del 70%. El brote se registró originalmente en Liberia y Guinea, y posteriormente se han repostado casos en Nigeria, Sierra Leona y Senegal. Todos los casos confirmados por laboratorio han sido positivos al vírus del Ébola. La fuente inicial del brote se localizó en la aldea de Meliandou, prefectura de Guáckádou, Guinea. El caso índice fue un niño de 2 años, el cual falleció el 6 de diciembre de 2013. Su madre, hermana y abuela también fallecieron también por la enfermedad. La gente de la aldea infectada por estas víctimas iniciales transmitió el brote a aldeas aledañas. El brote se esparció inicialmente a Liberia y posteriormente a Sierra Leona. En los tres países continúa la circulación del virus. La llegada de algunos casos a Nigeria y Senegal obligó a dichos países a cerrar sus fronteras, y a poner en cuarentena a ciudadanos de los que se sospechara que estuvieran infectados. Hasta la fecha, ambos países no han presentado casos nuevos, por lo que se consideran en control. Asimismo, se han reportado casos importados de dichos países en Estados Unidos, Francia, Alemania, España, Suiza y el Reino Unido.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Since the onset of the outbreak im December 2013 and up to the September 20 cut-off, there have been 2,909 deaths in the 6,185 likely cases of Ebola. It is considered that the letality under 50%, considerably lower tan the one reported in previous outbreaks of the disease, is biased due to the dificulty to collect and analyze information. On September 23, WHO showed a review of such estimations, indicating 70% letality. The outbreak was originally reported in Liberia and Guinea. Further cases were reported in Nigeria, Sierra Leone, and Senegal. All the cases confirmed by laboratory have been EBOV positive. The initial source of the outbreak was found in the village called Meliandou in the in Guéckédou Prefecture, Guinea. The index case was a two-year-old boy, who die don December 6, 2013. His mother, sister and grandmother also died because of the disease. The people from this village transmitted the disease to people in nera-by villages. The outbreak initially spread to Liberia and then to Sierra Leone. Virus circulation continues in three countries. The transmision of some cases to Nigeria and Senegal led these countries to close their borders to the three formerly mentioned countries and quarantine suspicious individuals. So far, neither country has presented new cases; hence they are considered under control. Likewise, cases imported from those countries into the United States, France, Germany, spain, Switzerland, and the Uited Kingdom have been reported.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[virus del Ébola]]></kwd>
<kwd lng="es"><![CDATA[África Occidental]]></kwd>
<kwd lng="es"><![CDATA[Zaire ebolavirus]]></kwd>
<kwd lng="en"><![CDATA[Ebola virus]]></kwd>
<kwd lng="en"><![CDATA[West Africa]]></kwd>
<kwd lng="en"><![CDATA[Zaire ebolavirus]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>Centers for Disease Control and prevention (CDC)</collab>
<source><![CDATA[Bioterrorism agents/diseases]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Transmission of Ebola hemorrhagic fever a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies a` Kikwit]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dowell]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Mukunu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ksiazek]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Rollin]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
</person-group>
<source><![CDATA[J Infect Dis]]></source>
<year>1999</year>
<volume>179</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>S87-91</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[De Roo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guimard]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Trappier]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bressler]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[J Infect Dis]]></source>
<year>1999</year>
<volume>179</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
<page-range>S170-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pathogenesis of the viral hemorrhagic fevers]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paessler]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
</person-group>
<source><![CDATA[Annu Rev Pathol]]></source>
<year>2013</year>
<volume>8</volume>
<page-range>411-40</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Keller]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clin Microbiol]]></article-title>
<collab>Stiehm ER "Passive immunity in prevention and treatment of infectious diseases"</collab>
<source><![CDATA[Rev]]></source>
<year>2000</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>602-14</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Langreth]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Ebola Drug by Tekmira May Be Used on Infected Patients]]></source>
<year>2014</year>
<publisher-name><![CDATA[Bloomberg News]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oestereich]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lü dtke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wurr]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rieger]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz-Fontela]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Günther]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model]]></article-title>
<collab>S</collab>
<source><![CDATA[Antiviral Res]]></source>
<year>2014</year>
<volume>105</volume>
<page-range>17-21</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ebola virus vaccines an overview of current approaches]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Feldmann]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Expert Rev Vaccines]]></source>
<year>2014</year>
<volume>13</volume>
<page-range>521-31</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Emergence of Zaire Ebola Virus Disease in Guinea-preliminary report]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baize]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pannetier]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Oestereich]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rieger]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Koivogui]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Magassouba]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ebola Virus Disease in West Africa - The First 9 Months of the Epidemic and Forward Projections]]></article-title>
<collab>WHO Ebola Response Team</collab>
<source><![CDATA[N Engl J Med]]></source>
<year>2014</year>
<volume>371</volume>
<page-range>1481-95</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Understanding the dynamics of Ebola epidemics]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Legrand]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Grais]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Boelle]]></surname>
<given-names><![CDATA[PY]]></given-names>
</name>
<name>
<surname><![CDATA[Valleron]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Flahault]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Epidemiol Infect]]></source>
<year>2007</year>
<volume>135</volume>
<page-range>610-21</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Transmissibility of 1918 pandemic influenza]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mills]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Robins]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Lipsitch]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Nature]]></source>
<year>2004</year>
<volume>432</volume>
<page-range>904-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
